| Dr Franklin Johnson, MD | |
|
90 Main St, Mineola, NY 11501-4080 | |
| (516) 742-3388 | |
| (516) 742-3931 |
| Full Name | Dr Franklin Johnson |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 90 Main St, Mineola, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457415408 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 117553 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Franklin Johnson, MD 90 Main St, Mineola, NY 11501-4080 Ph: (516) 742-3388 | Dr Franklin Johnson, MD 90 Main St, Mineola, NY 11501-4080 Ph: (516) 742-3388 |
News Archive
Scientists have long known that control mechanisms known collectively as "epigenetics" play a critical role in human development, but they did not know precisely how alterations in this extra layer of biochemical instructions in DNA contribute to development.
Most patients with an inherited heart condition known as arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) don't know they have a problem until they're in their early 20s. The lack of symptoms at younger ages makes it very difficult for researchers to study how ARVD/C evolves or to develop treatments. A new stem cell-based technology created by 2012 Nobel Prize winner Shinya Yamanaka, M.D., Ph.D., helps solve this problem.
Although mutations in a gene dubbed "the guardian of the genome" are widely recognized as being associated with more aggressive forms of cancer, researchers at the University of California, San Diego School of Medicine have found evidence suggesting that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities, at least in squamous cell head and neck cancers.
Endo Pharmaceuticals today announced actions designed to advance the company's leadership and growth in pain management, including an agreement to acquire all outstanding shares of Penwest Pharmaceuticals for $5.00 in cash per share, or an estimated enterprise value of approximately $144 million at the time of deal close. Penwest has been working with Endo since 1997 on the development and commercialization of OPANA® ER and receives a royalty stream on net sales of the product.
Exposure to something that whets the appetite, such as a picture of a mouthwatering dessert, can make a person more impulsive with unrelated purchases, finds a study from the February 2008 issue of the Journal of Consumer Research.
› Verified 9 days ago
Dr. Viktor B Smirnov, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Old Country Rd Ste 101, Mineola, NY 11501 Phone: 516-741-4138 | |
Alisha R Oropallo, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Mineola Blvd, Suite 300, Mineola, NY 11501 Phone: 516-663-4400 Fax: 516-663-4404 | |
Dr. Narinder Paul Grewal, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 173 Mineola Blvd Ste 401, Mineola, NY 11501 Phone: 516-663-1145 | |
Dr. John Mcnelis, MD Surgery Medicare: Medicare Enrolled Practice Location: 120 Mineola Blvd, Mineola, NY 11501 Phone: 516-663-3300 Fax: 516-663-2780 | |
Eihab Nail Abdelfatah, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 120 Mineola Blvd Ste 320, Mineola, NY 11501 Phone: 516-663-2436 | |
Dr. Loretto Glynn, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-4600 | |
Reese A Wain, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 120 Mineola Blvd, Suite 300, Mineola, NY 11501 Phone: 516-663-4400 Fax: 516-663-4404 |